Explore more publications!
Vanuatu Health Times
Got News to Share?

Vanuatu Health Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Vanuatu Health Times.

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

December 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30 31

January 2026

Mo Tu We Th Fr Sa Su
1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31

Press releases published on January 14, 2026

Glucose Health, Inc. Reports Debt-Free Balance Sheet and Previews New Soluble Fiber Brand
January 14, 2026

Glucose Health, Inc. Reports Debt-Free Balance Sheet and Previews New Soluble Fiber Brand

Indeterminate GlobeNewswire
NRx Pharmaceuticals (Nasdaq:NRXP) Announces 70,000 Patient Data on Real World Use of Ketamine for Treatment of Suicidal Depression to be Submitted to the FDA in Support of NRX-100 Approval
January 14, 2026

NRx Pharmaceuticals (Nasdaq:NRXP) Announces 70,000 Patient Data on Real World Use of Ketamine for Treatment of Suicidal Depression to be Submitted to the FDA in Support of NRX-100 Approval

Indeterminate GlobeNewswire
C4 Therapeutics Outlines Strategic Milestones to Advance Cemsidomide as a Potential Best-in-Class IKZF1/3 Degrader and Discovery Strategy Focused on Novel Targets in Clinically Validated Pathways
January 14, 2026

C4 Therapeutics Outlines Strategic Milestones to Advance Cemsidomide as a Potential Best-in-Class IKZF1/3 Degrader and Discovery Strategy Focused on Novel Targets in Clinically Validated Pathways

Indeterminate GlobeNewswire
RetinalGenix Reports on its Science and Mission in Light of New AI-Driven Retinal Mapping Study
January 14, 2026

RetinalGenix Reports on its Science and Mission in Light of New AI-Driven Retinal Mapping Study

Indeterminate GlobeNewswire
Verano Strengthens National Product Portfolio in Industry’s Fastest-Growing Category with Launch of Swift Lifts as Standalone Pre-roll Brand
January 14, 2026

Verano Strengthens National Product Portfolio in Industry’s Fastest-Growing Category with Launch of Swift Lifts as Standalone Pre-roll Brand

Indeterminate GlobeNewswire
Human Appeal Concludes First-Ever U.S. Winter Coat Drive
January 14, 2026

Human Appeal Concludes First-Ever U.S. Winter Coat Drive

Indeterminate GlobeNewswire
[Latest] Global T-Cell Engagers Market Size/Share Worth USD 18.8 Billion by 2034 at a 21.2% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)
January 14, 2026

[Latest] Global T-Cell Engagers Market Size/Share Worth USD 18.8 Billion by 2034 at a 21.2% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)

Indeterminate GlobeNewswire
Sisäpiiritieto: Orion antaa näkymäarvion vuodelle 2026 ja arvioi Orionin kirjaamalla vuotuisella Nubeqa®-liikevaihdolla olevan potentiaalia ylittää tulevaisuudessa miljardi euroa
January 14, 2026

Sisäpiiritieto: Orion antaa näkymäarvion vuodelle 2026 ja arvioi Orionin kirjaamalla vuotuisella Nubeqa®-liikevaihdolla olevan potentiaalia ylittää tulevaisuudessa miljardi euroa

Indeterminate GlobeNewswire
Inside information: Orion provides outlook for 2026 and estimates that the annual Nubeqa® net sales recorded by Orion has potential to exceed EUR 1 billion in the future
January 14, 2026

Inside information: Orion provides outlook for 2026 and estimates that the annual Nubeqa® net sales recorded by Orion has potential to exceed EUR 1 billion in the future

Indeterminate GlobeNewswire
De nouvelles données renforcent l’engagement d’Ipsen à proposer des solutions et à combler les lacunes de prise en charge dans les maladies neurologiques lors du congrès TOXINS
January 14, 2026

De nouvelles données renforcent l’engagement d’Ipsen à proposer des solutions et à combler les lacunes de prise en charge dans les maladies neurologiques lors du congrès TOXINS

Indeterminate GlobeNewswire
New data reinforces Ipsen’s commitment to bringing solutions and addressing care gaps in neurological diseases at TOXINS
January 14, 2026

New data reinforces Ipsen’s commitment to bringing solutions and addressing care gaps in neurological diseases at TOXINS

Indeterminate GlobeNewswire
HUTCHMED Highlights Publication of Phase III SACHI Results in The Lancet
January 14, 2026

HUTCHMED Highlights Publication of Phase III SACHI Results in The Lancet

Indeterminate GlobeNewswire
BriaCell Therapeutics Announces Pricing of $30 million Public Offering
January 14, 2026

BriaCell Therapeutics Announces Pricing of $30 million Public Offering

Indeterminate GlobeNewswire

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions